Patients switching from Pfizer’s branded cholesterol pill Lipitor to Merck & Co’s Zocor — now available as a cheap generic — are more likely to have a heart attack or die, according to a Pfizer-backed study. Go to the Story »
Discuss   Tell a friend   Bury
Add to:   submit 'Pfizer study shows risk of cholesterol pill switch' to del.icio.us   submit 'Pfizer study shows risk of cholesterol pill switch' to digg   submit 'Pfizer study shows risk of cholesterol pill switch' to reddit   submit 'Pfizer study shows risk of cholesterol pill switch' to simpy   submit 'Pfizer study shows risk of cholesterol pill switch' to yahoo   |   Bookmarks  

Comments Who Voted Related Links